Furthermore, two independent studies reported that in GC patients treated with neoadjuvant chemotherapy, the rate of positive LGR5 expression was higher in the resected specimens exhibiting poor tumor regression compared to regressed tumors [66,72]. This evidence concerns the gene LGR5 and gastric cancer.